enGene Holdings Inc.enGene Holdings Inc.enGene Holdings Inc.

enGene Holdings Inc.

No trades
See on Supercharts

ENGN fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
ENGN has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company